Table 3.
Non-users of psychotropic molecules n = 115 | Users of psychotropic molecules n = 62 | p-value | |
---|---|---|---|
Age | 67.77 ± 9.13 | 72.49 ± 8.74 | <.001b |
Education (years) | 12.00 ± 4.07 | 11.09 ± 3.89 | NSb |
Falls with injury, number (%) | 61 (60.40%) | 51 (67.11%) | NSc |
Risk factors of falls | 0.80 ± 0.75 | 1.01 ± 1.11 | NSb |
Number of prescribed molecules | 3.37 ± 3.02 | 7.39 ± 3.97 | <.001b |
Comorbidities | 1.50 ± 1.28 | 2.09 ± 1.57 | <.009b |
Handgrip strength (kg) | 23.13 ± 8.59 | 20.79 ± 8.13 | .023b |
BMI | 27.20 ± 4.96 | 27.75 ± 5.09 | NSa |
MMSE score | 28.29 ± 1.86 | 26.95 ± 2.96 | .002b |
MoCA score | 27.48 ± 2.77 | 25 ± 5.14 | <.001b |
TMT A, completion time (sec) | 36.24 ± 14.74 | 43.43 ± 22.87 | .006 b |
TMT B, completion time (sec) | 84.91 ± 38.78 | 108.73 ± 57.04 | .001b |
TMT B-A (sec) | 49.29 ± 31.82 | 69.58 ± 49.54 | .001b |
TUG score (sec) | 8.70 ± 1.75 | 10.36 ± 4.18 | .002b |
Unless indicated, values are mean ± SD; aStudent’s t-test, bMann-Whitney U test, cChi square test, NS (non-significant), SD (standard deviation).